Lv11
50 积分 2025-06-30 加入
Cost-effectiveness analysis of niraparib maintenance therapy in Chinese patients with platinum-sensitive recurrent ovarian cancer
1小时前
已完结
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study
8天前
已完结
Fuzuloparib as maintenance therapy among patients with advanced ovarian cancer after a response to first-line platinum-based chemotherapy: Results from a randomized, placebo-controlled, phase III trial
1个月前
已完结
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer
3个月前
已关闭
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer
3个月前
已关闭
Construction of a knowledge graph for diabetes complications from expert-reviewed clinical evidences
3个月前
已完结
Progression-free survival of niraparib in patients with platinum-sensitive recurrent ovarian cancer: meta-analysis
3个月前
已关闭
Predicting Adverse Drug Reactions in Oncology: A Critical Review of Machine Learning Approaches and Future Directions
3个月前
已关闭
Durvalumab plus paclitaxel/carboplatin plus bevacizumab followed by durvalumab, bevacizumab plus olaparib maintenance among patients with newly-diagnosed advanced ovarian cancer without a tumor BRCA1/BRCA2 mutation: Updated results from DUO-O/ENGOT-OV46/GOG-3025 Trial
4个月前
已完结
First evidence of olaparib maintenance therapy in patients with newly diagnosed homologous recombination deficient positive/BRCA wild-type ovarian cancer: real-world multicenter study
4个月前
已完结
皖公网安备34019202002308
